- Home
- HKPD vs RANI Comparison
HKPD vs RANI Comparison
Compare HKPD & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- RANI
- Stock Information
- Founded
- HKPD 2016
- RANI 2012
- Country
- HKPD Hong Kong
- RANI United States
- Employees
- HKPD N/A
- RANI N/A
- Industry
- HKPD Other Pharmaceuticals
- RANI Medicinal Chemicals and Botanical Products
- Sector
- HKPD Health Care
- RANI Health Care
- Exchange
- HKPD Nasdaq
- RANI Nasdaq
- Market Cap
- HKPD 20.9M
- RANI 24.2M
- IPO Year
- HKPD 2025
- RANI 2021
- Fundamental
- Price
- HKPD $1.34
- RANI $0.51
- Analyst Decision
- HKPD
- RANI Strong Buy
- Analyst Count
- HKPD 0
- RANI 4
- Target Price
- HKPD N/A
- RANI $7.75
- AVG Volume (30 Days)
- HKPD 333.5K
- RANI 261.1K
- Earning Date
- HKPD 08-14-2025
- RANI 11-13-2025
- Dividend Yield
- HKPD N/A
- RANI N/A
- EPS Growth
- HKPD N/A
- RANI N/A
- EPS
- HKPD N/A
- RANI N/A
- Revenue
- HKPD $20,313,818.00
- RANI $1,200,000.00
- Revenue This Year
- HKPD N/A
- RANI N/A
- Revenue Next Year
- HKPD N/A
- RANI N/A
- P/E Ratio
- HKPD N/A
- RANI N/A
- Revenue Growth
- HKPD 21.72
- RANI N/A
- 52 Week Low
- HKPD $0.81
- RANI $0.39
- 52 Week High
- HKPD $3.79
- RANI $3.75
- Technical
- Relative Strength Index (RSI)
- HKPD 48.60
- RANI 50.79
- Support Level
- HKPD $1.51
- RANI $0.47
- Resistance Level
- HKPD $1.52
- RANI $0.53
- Average True Range (ATR)
- HKPD 0.15
- RANI 0.03
- MACD
- HKPD -0.02
- RANI 0.00
- Stochastic Oscillator
- HKPD 23.81
- RANI 58.00
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.